Francisco Partners takes Weave Communications private

At $7.40/share (~$650M equity), Francisco Partners is paying a 34% premium to the pre-announcement close but acquiring at less than half of Weave's implied peak equity value of over $1.4 billion when it IPO'd at $22.40 in November 2021 — and the 2.7x trailing revenue multiple sits exactly at the current healthcare vertical SaaS median, meaning Francisco got no discount for scale but paid nothing for the premium the stock once commanded. The stated rationale is accelerating investment in Weave's payments and revenue cycle management capabilities, which fits a clear FP pattern: the firm already owns AdvancedMD, acquired for $1.125B from Global Payments, and assembled Merative from IBM's Watson Health assets, so Weave's 40,000 SMB practice locations drop directly into a healthcare stack that was missing a front-end patient engagement and payments layer. Despite 17% revenue growth, Weave had been trading down on SaaSpocalypse sentiment, and even after the 32% deal-day surge the stock remained negative on a one-year basis — which tells you this market is still pricing growth-stage vertical SaaS on fear rather than fundamentals, and that FP is willing to step in at public-market-distressed levels to consolidate a healthcare IT stack it can own end-to-end.

Spotted an error or advised on this transaction? Claim credit or send a correction

Browse the full register →